Lnu
Basannagouda Lnu, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20140253211 | LOW VOLTAGE LEVEL SHIFTER FOR LOW POWER APPLICATIONS - A level shifter circuit for low power applications that can shift the level of a digital signal that is below the threshold voltage of output transistors. The level shifter uses core transistors in the input stage and includes an intermediate stage that limits the voltage applied to the drain of the core transistors. The intermediate stage may include two transistors whose gate is connected to a reference voltage and turns off when the voltage at their source is equal to a threshold voltage below the reference voltage, thus limiting the maximum voltage applied to the transistors present in the input stage. | 09-11-2014 |
Shrikant Sundaram Lnu, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150365355 | HIERARCHICAL STATISTICALLY MULTIPLEXED COUNTERS AND A METHOD THEROF - Embodiments of the present invention relate to an architecture that uses hierarchical statistically multiplexed counters to extend counter life by orders of magnitude. Each level includes statistically multiplexed counters. The statistically multiplexed counters includes P base counters and S subcounters, wherein the S subcounters are dynamically concatenated with the P base counters. When a row overflow in a level occurs, counters in a next level above are used to extend counter life. The hierarchical statistically multiplexed counters can be used with an overflow FIFO to further extend counter life. | 12-17-2015 |
Sooryanarayana Lnu, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20090012031 | EZH2 Cancer Markers - The present invention relates to therapeutic targets for cancer. In particular, the present invention relates to small molecules and nucleic acids that target EZH2 expression in prostate cancer. | 01-08-2009 |
20100222420 | COMPOSITIONS AND METHODS FOR INHIBITING EZH2 - The present invention relates to therapeutic targets for cancer. In particular, the present invention relates to small molecules and nucleic acids that target EZH2 expression in prostate cancer. | 09-02-2010 |
Sooryanaryana Lnu, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20110207198 | COMPOSITIONS AND METHODS FOR INHIBITING MMSET - The present invention relates to agents that find use in the treatment, management, and/or study of cancer. In particular, the present invention relates to agents (e.g., small molecules, nucleic acids) that affect MMSET expression or activity. | 08-25-2011 |
20110251216 | COMPOSITIONS AND METHODS FOR INHIBITING EZH2 - The present invention relates to therapeutic targets for cancer. In particular, the present invention relates to small molecules and nucleic acids that target EZH2 expression in cancer (e.g., prostate cancer, breast cancer, other solid tumors, multiple myeloma). | 10-13-2011 |